ENDRA Life Sciences Provides a Business Update and Reports Second Quarter 2025 Financial Results
ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #MASH--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo-Acoustic Enhanced UltraSound (TAEUS®), today provided a business update and reported ...
What are the key risks (regulatory, technical, competitive) if the enhanced TAEUS Liver system does not achieve the projected accuracy improvements?
Are there any partnership, licensing, or acquisition opportunities that could arise from the enhanced technology?
How will this business update affect key valuation multiples (P/E, EV/EBITDA) and current analyst price targets?
17 days ago